ArticleAmerican journal of hematology2026

Dexamethasone for Management of Cytokine Release Syndrome Associated With Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma.

Jessica McElwee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.